Details for New Drug Application (NDA): 065329
✉ Email this page to a colleague
The generic ingredient in CEFTRIAXONE is ceftriaxone sodium. There are twenty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ceftriaxone sodium profile page.
Summary for 065329
Tradename: | CEFTRIAXONE |
Applicant: | Acs Dobfar |
Ingredient: | ceftriaxone sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 065329
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INJECTION | 065329 | ANDA | Sagent Pharmaceuticals | 25021-106 | 25021-106-10 | 25 VIAL in 1 CARTON (25021-106-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INJECTION | 065329 | ANDA | Sagent Pharmaceuticals | 25021-107 | 25021-107-20 | 25 VIAL in 1 CARTON (25021-107-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | Jul 24, 2008 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | Jul 24, 2008 | TE: | AP | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
Approval Date: | Jul 24, 2008 | TE: | AP | RLD: | No |
Complete Access Available with Subscription